{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:58:35Z","timestamp":1792511915774,"version":"4.5.0"},"reference-count":28,"publisher":"American Diabetes Association","issue":"11","license":[{"start":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:00:00Z","timestamp":1476921600000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Although never assessed prospectively, diabetes mellitus (DM) is assumed to negatively affect the outcomes of critical limb ischemia (CLI). DM was highly prevalent in two recently conducted randomized controlled trials in CLI patients, the PADI (Percutaneous Transluminal Balloon Angioplasty [PTA] and Drug Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia) and JUVENTAS (Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-Arterial Supplementation) trials. To determine the implications of DM in a population of patients with infrapopliteal CLI, clinical outcomes were compared in patients with and without DM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Individual data from patients with CLI (Rutherford category \u22654) were pooled. Patients were considered to have DM when this diagnosis was reported in the hospital electronic medical records. Rates of major amputation (above ankle level) and major events (major amputation or death) were compared between CLI patients with and without DM. Hazard ratios (HRs) were calculated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Of a total of 281 patients, DM was present in 49.1%. The major amputation rate at 5 years of follow-up was higher in patients with DM than in patients without DM (34.1% vs. 20.4%, P = 0.015). The major event and death rate did not differ. The unadjusted HR of DM for the major amputation risk was 1.87 (95% CI 1.12\u20133.12). Model factors with significant HRs in the multivariate analysis were baseline Rutherford category (HR 1.95; 95% CI 1.24\u20133.06) and ankle-brachial index (ABI) &amp;gt;1.4 (HR 2.78; 95% CI 1.37\u20135.64).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>CLI patients with DM are at a significantly higher risk of major amputation than CLI patients without DM. This increased risk is associated with a higher prevalence of baseline ABI &amp;gt;1.4 and more severe ischemia at initial presentation in patients with DM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc16-0850","type":"journal-article","created":{"date-parts":[[2016,9,10]],"date-time":"2016-09-10T02:00:15Z","timestamp":1473472815000},"page":"2058-2064","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":82,"title":["Diabetes Is Associated With Decreased Limb Survival in Patients With Critical Limb Ischemia: Pooled Data From Two Randomized Controlled Trials"],"prefix":"10.2337","volume":"39","clinical-trial-number":[{"clinical-trial-number":"nct00471289","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00371371","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Marlon I.","family":"Spreen","sequence":"first","affiliation":[{"name":"Department of Radiology, Haga Teaching Hospital, The Hague, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Gremmels","sequence":"additional","affiliation":[{"name":"Department of Nephrology & Hypertension, University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Teraa","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf W.","family":"Sprengers","sequence":"additional","affiliation":[{"name":"Department of Radiology, University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne C.","family":"Verhaar","sequence":"additional","affiliation":[{"name":"Department of Nephrology & Hypertension, University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph G.","family":"Statius van Eps","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Haga Teaching Hospital, The Hague, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul P.M.","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, St. Antonius Hospital, Nieuwegein, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem P.Th.M.","family":"Mali","sequence":"additional","affiliation":[{"name":"Department of Radiology, University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"van Overhagen","sequence":"additional","affiliation":[{"name":"Department of Radiology, Haga Teaching Hospital, The Hague, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the PADI and JUVENTAS Study Groups","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2016,9,9]]},"reference":[{"key":"2022031301070190500_B1"},{"key":"2022031301070190500_B2","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.jacc.2008.02.041","article-title":"Footnotes on critical limb ischemia","volume":"51","author":"Feiring","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2022031301070190500_B3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002938","article-title":"Critical limb ischemia: current trends and future directions","volume":"5","author":"Teraa","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2022031301070190500_B4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0741-5214(03)00092-2","article-title":"Functional outcome in a contemporary series of major lower extremity amputations","volume":"38","author":"Nehler","year":"2003","journal-title":"J Vasc Surg"},{"key":"2022031301070190500_B5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1464-5491.2009.02866.x","article-title":"Peripheral arterial disease in diabetes--a review","volume":"27","author":"Jude","year":"2010","journal-title":"Diabet Med"},{"key":"2022031301070190500_B6","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2337\/diacare.26.12.3333","article-title":"Peripheral arterial disease in people with diabetes","volume":"26","author":"American Diabetes Association","year":"2003","journal-title":"Diabetes Care"},{"key":"2022031301070190500_B7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ejvs.2013.02.014","article-title":"Evidence-based management of PAD & the diabetic foot","volume":"45","author":"Brownrigg","year":"2013","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2022031301070190500_B8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.114.012913","article-title":"Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) trial","volume":"131","author":"Teraa","year":"2015","journal-title":"Circulation"},{"key":"2022031301070190500_B9","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jvs.2010.02.020","article-title":"Rationale and design of the JUVENTAS trial for repeated intra-arterial infusion of autologous bone marrow-derived mononuclear cells in patients with critical limb ischemia","volume":"51","author":"Sprengers","year":"2010","journal-title":"J Vasc Surg"},{"key":"2022031301070190500_B10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia: revised version","volume":"26","author":"Rutherford","year":"1997","journal-title":"J Vasc Surg"},{"key":"2022031301070190500_B11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jvs.2009.04.073","article-title":"Update on PADI trial: percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia","volume":"50","author":"Martens","year":"2009","journal-title":"J Vasc Surg"},{"key":"2022031301070190500_B12","doi-asserted-by":"crossref","first-page":"e002376","DOI":"10.1161\/CIRCINTERVENTIONS.114.002376","article-title":"Percutaneous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial","volume":"9","author":"Spreen","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"2022031301070190500_B13","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1093\/eurheartj\/eht142","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II","volume":"34","author":"Beckman","year":"2013","journal-title":"Eur Heart J"},{"key":"2022031301070190500_B14","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2337\/dc07-2424","article-title":"Outcome after leg bypass surgery for critical limb ischemia is poor in patients with diabetes: a population-based cohort study","volume":"31","author":"Malmstedt","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031301070190500_B15","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1161\/CIR.0b013e318276fbcb","article-title":"Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association","volume":"126","author":"Aboyans","year":"2012","journal-title":"Circulation"},{"key":"2022031301070190500_B16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Fowkes","year":"2008","journal-title":"JAMA"},{"key":"2022031301070190500_B17","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jvs.2010.10.054","article-title":"The prognosis of diabetic patients with high ankle-brachial index depends on the coexistence of occlusive peripheral artery disease","volume":"53","author":"Aboyans","year":"2011","journal-title":"J Vasc Surg"},{"key":"2022031301070190500_B18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/j.jfas.2014.12.022","article-title":"Lower extremity amputation risk factors associated with elevated ankle brachial indices and radiographic arterial calcification","volume":"54","author":"Lew","year":"2015","journal-title":"J Foot Ankle Surg"},{"key":"2022031301070190500_B19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5694\/j.1326-5377.1967.tb20983.x","article-title":"Comparative study of arterial disease in amputated lower limbs from diabetics and non-diabetics (with special reference to feet arteries)","volume":"1","author":"Ferrier","year":"1967","journal-title":"Med J Aust"},{"key":"2022031301070190500_B20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1191\/1358863x06vm678oa","article-title":"Falsely high ankle-brachial index predicts major amputation in critical limb ischemia","volume":"11","author":"Silvestro","year":"2006","journal-title":"Vasc Med"},{"key":"2022031301070190500_B21","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.2337\/diacare.24.12.2107","article-title":"Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patients","volume":"24","author":"Suzuki","year":"2001","journal-title":"Diabetes Care"},{"key":"2022031301070190500_B22","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jacc.2010.05.050","article-title":"Bisphosphonate use and prevalence of valvular and vascular calcification in women MESA (The Multi-Ethnic Study of Atherosclerosis)","volume":"56","author":"Elmariah","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2022031301070190500_B23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.atherosclerosis.2008.07.010","article-title":"High dietary menaquinone intake is associated with reduced coronary calcification","volume":"203","author":"Beulens","year":"2009","journal-title":"Atherosclerosis"},{"key":"2022031301070190500_B24","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.2013.2107","article-title":"Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial","volume":"309","author":"Lamas","year":"2013","journal-title":"JAMA"},{"key":"2022031301070190500_B25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/dmrr.2704","article-title":"Performance of prognostic markers in the prediction of wound healing or amputation among patients with foot ulcers in diabetes: a systematic review","volume":"32","author":"Brownrigg","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"2022031301070190500_B26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/archsurg.139.4.395","article-title":"Major lower extremity amputation: outcome of a modern series","volume":"139","author":"Aulivola","year":"2004","journal-title":"Arch Surg"},{"key":"2022031301070190500_B27","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.2337\/dc06-0926","article-title":"Mortality and hospitalization in patients after amputation: a comparison between patients with and without diabetes","volume":"29","author":"Schofield","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031301070190500_B28"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/39\/11\/2058\/546004\/dc160850.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/39\/11\/2058\/546004\/dc160850.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T04:44:35Z","timestamp":1647146675000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/39\/11\/2058\/37216\/Diabetes-Is-Associated-With-Decreased-Limb"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,9]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,9,9]]},"published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc16-0850","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,9]]}}}